Your browser doesn't support javascript.
loading
Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy.
Dalin, Frida; Adamus, Grazyna; Yang, Sufang; Landgren, Eva; Palle, Josefine; Hallgren, Åsa; Frost, Britt-Marie; Hugosson, Therése; Landegren, Nils; Eriksson, Daniel; Andréasson, Sten; Tabbara, Khalid F; Kämpe, Olle; Alimohammadi, Mohammad.
Afiliação
  • Dalin F; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: Frida.dalin@ki.se.
  • Adamus G; Ocular Immunology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon.
  • Yang S; Ocular Immunology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon.
  • Landgren E; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Palle J; Department of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden.
  • Hallgren Å; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Frost BM; Department of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden.
  • Hugosson T; Department of Clinical Sciences, Ophthalmology, Lund University, Lund, Sweden.
  • Landegren N; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Eriksson D; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Andréasson S; Department of Clinical Sciences, Ophthalmology, Lund University, Lund, Sweden.
  • Tabbara KF; The Eye Center, Riyadh, Saudi Arabia.
  • Kämpe O; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Alimohammadi M; Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Ophthalmology ; 123(6): 1401-4, 2016 06.
Article em En | MEDLINE | ID: mdl-26854037
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Neoplasias Ósseas / Calcâneo / Regulação Neoplásica da Expressão Gênica / Peptídeos e Proteínas de Sinalização Intracelular / Síndromes Paraneoplásicas Oculares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Neoplasias Ósseas / Calcâneo / Regulação Neoplásica da Expressão Gênica / Peptídeos e Proteínas de Sinalização Intracelular / Síndromes Paraneoplásicas Oculares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article